QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Background: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). Objective: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Arun R. Sridhar, MBBS, MPH, Neal A. Chatterjee, MD, MSc, Basil Saour, MD, Dan Nguyen, MD, Elizabeth A. Starnes, ARNP, Christine Johnston, MD, MPH, Margaret L. Green, MD, MPH, Gregory A. Roth, MD, Jeanne E. Poole, MD, FHRS
פורמט: Article
שפה:English
יצא לאור: Elsevier 2020-08-01
סדרה:Heart Rhythm O2
נושאים:
Coronavirus
Electrocardiogram
Hydroxychloroquine
QT interval
Ventricular arrhythmia
גישה מקוונת:http://www.sciencedirect.com/science/article/pii/S2666501820300751

אינטרנט

http://www.sciencedirect.com/science/article/pii/S2666501820300751

פריטים דומים